Clinical trial
Vascular Effect of CIMICIFUGA RACEMOSA Versus Placebo Evaluated by Flow Mediated Dilatation of Brachial Artery (CRDILA)
NCT03786809 is registered in ClinicalTrials.gov with Federal University of Minas Gerais as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vascular Effect of CIMICIFUGA RACEMOSA Versus Placebo Evaluated by Flow Mediated Dilatation of Brachial Artery (CRDILA)
- Lead sponsor
- Federal University of Minas Gerais
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- May 31, 2019
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postmenopausal symptoms